Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel leukotriene antagonist with potential in asthma therapy

Feb. 19, 1998

New hope for patients diagnosed with malignant pleural effusions

Feb. 18, 1998

Klinge discovers compounds for asthma with high efficacy and safety

Feb. 18, 1998

Olopatadine still under regulatory review in Japan

Feb. 18, 1998

Substance P antagonists revealed by Boehringer Ingelheim

Feb. 18, 1998

Dual inhibitors of PDE IV and TNF production prepared at Chiroscience

Feb. 17, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Feb. 12, 1998

Lilly describes second-generation NK1 antagonist

Feb. 11, 1998

Safety warnings issued by FDA for Hismanal

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...